Rabbit Anti-Human ENA-78

Slide this table

Cat-Nr.102-P07
Size100 µg
Price235 €
CategoryPolyclonal Antibody
Clone Nr.Rabbit IgG
Species ReactivityHuman
Formulationlyophilized from PBS
BufferPBS
ReconstitutionReconstitute in sterile water to a concentration of 0.1-1.0mg/mL.
Stability and StorageThe lyophilized antibody is stable for at least 2 years from date of receipt at -20°C. The reconstituted antibody is stable for at least two weeks at 2-8°C. Frozen aliquots are stable for at least 6 months when stored at -20°C.
PreparationProduced from sera of rabbits pre-immunized with highly pure (>98%) recombinant human ENA 78 (human Epithelial Neutrophil Activating Peptide-78). Anti-human ENA 78 specific antibody was purified by affinity chromatography employing immobilized human ENA 78 matrix.
AntigenRecombinant Human ENA-78 (CXCL5)
ApplicationELISA, WB, N
SynonymsCXCL5; SCYB5; ENA-78
DescriptionEpithelial cell-derived-neutrophi-lactivating-peptide (ENA78) also known as CXCL5, is an 8 kDa proinflammatory member of the CXC subfamily of chemokines. Its GluLeuArg (ELR) motif confers angiogenic properties and distinguishes it from ELRCXC chemokines which are angiostatic. Human CXCL5 shares 57% amino acid (aa) sequence identity with mouse and rat CXCL5. Among other human ELR+ chemokines, it shares 77% aa sequence identity with CXCL6/GCP2 and 35%51% with CXCL1/GRO alpha, CXCL2/GRO beta, CXCL3/GRO gamma, CXCL7/NAP2, and CXCL8/IL8. Inflammatory stimulation upregulates CXCL5 production in multiple hematopoietic cell types, fibroblasts, endothelial cells, and vascular smooth muscle cells. In vivo, CXCL5 is elevated at sites of inflammation and pulmonary fibrosis where it promotes neutrophil infiltration and activation as well as angiogenesis. Its upregulation contributes to increased vascularization, tumor growth, and metastasis in many cancers. Full length CXCL5 (78 aa) is trimmed at the N-terminal end by Cathepsin G and chymotrypsin to ENA74 (74 aa) and ENA70 (70 aa), with the shortened forms showing increased potency relative to full length CXCL5. CXCL5 exerts its effects primarily through interactions with CXCR2. It also binds DARC, a decoy chemokine receptor which can limit CXCR2-mediated responses.
Uniprot IDP42830
Protein RefSeqNP_002985.1
mRNA RefSeqNM_002994.3

All prices plus VAT + possible delivery charges